Please login to the form below
drug pricing
This page shows the latest drug pricing news and features for those working in and with pharma, biotech and healthcare.
Pfizer, Sanofi and others set to increase US drug prices in 2021
Drug pricing will also be a focus of the incoming President-elect, Joe Biden, who has promised to reduce drug prices in the US. ... One key tenet of Biden’s drug pricing pledge is to allow Medicare to negotiate drug prices directly with pharma companies
Latest news
-
Moderna looks to price COVID-19 vaccine at $50-$60 per course
Shines spotlight on pricing strategies for potential vaccines. COVID-19 vaccine frontrunner Moderna is allegedly looking to price its candidate at around $50-$60 per course, according to a report from ... According to the report, Moderna’s proposed
-
Lilly joins new Medicare scheme to reduce insulin prices
of-pocket drug costs.
-
FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging
Phoenixus has resisted pressure to lower the price of the drug, and is reportedly haemorrhaging cash – a situation which will presumably only get worse once the generic is available. ... Gaming tactics include preventing generic drugmakers getting
-
Ex-Sandoz exec admits role in generic drug price-fixing plot
The two named products are clobetasol, an eczema and psoriasis treatment, and nystatin triamcinolone, an anti-fungal drug that also has a corticosteroid. ... Drug pricing is a particularly hot-topic among US politicians at the moment, and has snowballed
-
Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price
GENEr8-1 trial of the drug – enough to meet the pre-specified criteria for regulatory review. ... The uncertainty of the durability of BioMarin’s drug has left space for other haemophilia A hopefuls from rival developers.
More from news
Approximately 72 fully matching, plus 197 partially matching documents found.
Latest Intelligence
-
The search for effective drug treatments for COVID-19
What are the specific challenges of getting scientific consensus during a rapidly developing drug process in the midst of a global pandemic? ... How does pricing for the drug in the EU compare to pricing in the US?
-
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski. Eliminating pharmacy benefit manager (PBM) rebates has been proposed to address several healthcare issues associated with pharmaceutical pricing (eg, increasing patient prescription drug costs) but ... Due to
-
The impact of COVID-19 on clinical trials
Based on our discussions with venture capitalists, many anticipate potentially severe cash flow issues for drug developers. ... The impact of the pandemic on clinical trials is likely to be felt on a policy level, including in drug pricing negotiations.
-
Health trust in a COVID-19 world – a unique opportunity for pharma
Our team there hypothesised that this may be due to several highly publicised issues including Servier’s long-awaited trial over the safety of a weight loss drug, a large, monthslong ... hospital strike, increasing anti-vaccination sentiment and
-
Risks, reforms and rewards: the evolving Russian healthcare market
However, efforts to increase state control of drug pricing and pressure to manufacture medicines locally could prove a challenge for international drug companies.
More from intelligence
Approximately 7 fully matching, plus 39 partially matching documents found.
Latest appointments
-
New faces at Lucid Group and ZPB Associates
Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.
-
Pfizer’s Emms takes up ABPI presidency
Emms is no stranger to these issues, having served on the ABPI board and taken part in the negotiations over the future of drug pricing in the UK. ... He has not been afraid to criticise the outcomes of these discussions too, saying in November that the
-
Bayer's Martin Hesse moves to Daiichi Sankyo Europe
Commenting on the environment in which he starts at Daiichi, Hesse said securing the company's profitability and competitiveness in the light of drug pricing interventions will a major challenge.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
A panel of experts in pricing, chaired by our Senior Executive Advisor, Raf De Wilde, will discuss how best to navigate these pricing challenges and make sure you achieve the optimal ... Jaime Espin Former Member of the WHO Guideline Panel on Country
-
How to weather the pricing competiton
Over the years, the threat of pricing competition has increasingly become a concern. ... For the drug Saizen, Merck Serono was able to move out of tenders and into contracts.
-
Enabling market access through outcomes-based pricing
Furthermore, in disease areas where drug competition is high, the evidence gathered via outcomes-based pricing agreements can be used to drive market access by differentiating from competitor products, and targeting ... Staton, T. (2016). Most US payers
-
Pricing and Market Access Simulator
Reliable tool for value assessment of pipeline products. YOUR CHALLENGE:. PRICING A PRODUCT EARLY IN DEVELOPMENT. ... The pricing and market access simulator app offers you a unique opportunity to take early investment decisions more robustly than ever:.
-
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. ... Keeping reimbursement goals achievable. Pricing drugs and gaining reimbursement can be a real challenge for drug developers.
More from PMHub
Approximately 8 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Nucleus Global announces a trio of promotions
- UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
